Delivery Order SPE2DB20D3103-SPE2DB25FP5S3
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,735.08 firm fixed-price contract is for the supply of Potassium Chloride 10 MEQ/100 ML solution, with a final completion date of September 22, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 100ml solutions of 10 milliequivalents per 100ml potassium chloride. The contract has a firm fixed price of $1,549.73 and an ultimate completion date of December 2, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Potassium Chloride Extended Release 8 milliequivalent tablets in quantities of 500 units. This firm fixed price delivery order, valued at $6,588.65, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement supporting global pharmaceutical procurement for military...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Potassium Chloride Extended Release 10 milliequivalent capsules in quantities of 500, with a ceiling value of $1,146.60. This is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025, and represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Potassium Chloride Extended Release 10 MEQ tablets in quantities of 1,000 units, with a ceiling value of $1,611.86. This is a firm fixed-price delivery order with no set-aside designation, scheduled for completion by August 11, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $3,179.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Potassium Chloride Extended Release 10 MEQ on July 30, 2025, with a completion date of July 31, 2025. This non-set-aside contract represents a routine pharmaceutical procurement executed through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Potassium Chloride Extended-Release 10 MEQ capsules (500 count) valued at $1,024.41, with completion scheduled for August 1, 2025. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Potassium Chloride Extended-Release 10 MEQ capsules (500-count containers) under a firm fixed-price contract with a ceiling value of $1,544.08. This is a non-set-aside competitive award with an ultimate completion date of August 15, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $7,103.78 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Potassium Chloride Extended Release 10 MEQ tablets in quantities of 1,000 units. This competitively awarded, firm fixed price delivery order is scheduled for completion by August 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical distribution company. The $3,041.90 order is for the supply of potassium chloride 10% (40 mEq/30 mL) cups, a critical medical product used in military treatment programs and facilities. The delivery order was issued under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with a...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP5S3Delivery Order
The Defense Logistics Agency awarded a $1,146.36 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for Potassium Chloride 10 milliequivalents per 100 milliliters solution in 100-milliliter units. The contract is competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of July 21, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order is executed under AmerisourceBergen Drug Corp's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract reflects the company's established capability to fulfill federal medical supply requirements through competitive procurement and its integral role in supporting the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/18/25 |